"HCA Houston Healthcare Medical Center is a 444-bed acute care hospital proudly serving the Greater Houston area since 1975. Our hospital offers a wide range of medical services, including diagnostic testing and imaging, emergency care, general surgery, gynecological surgery, colorectal and gastrointestinal surgery. Located in the heart of Houston’s Museum District, our facility includes two intensive care units that allow for expert care for the most critical patients. We are an accredited chest pain center and multi-accredited bariatric surgery center. As a part of one of the largest healthcare systems in Houston, HCA Houston Healthcare, we are committed to providing accessible care. For more information, please visit our website."

During the past decade, HCA Houston Healthcare Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HCA Houston Healthcare Medical Center" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Edwards Lifesciences" with 3 trials sponsored, "Pharmacia and Upjohn" with 3 trials sponsored, "G D Searle" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

According to Clinical.Site data, the most researched conditions in "HCA Houston Healthcare Medical Center" are "HIV Infections" (5 trials), "Stroke" (2 trials), "Tricuspid Regurgitation" (2 trials), "Acute DVT of Lower Extremity" (1 trials) and "Aortic Stenosis, Calcific" (1 trials). Many other conditions were trialed in "HCA Houston Healthcare Medical Center" in a lesser frequency.

Most popular intervention types in "HCA Houston Healthcare Medical Center" are "Device" (12 trials), "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (3 trials), "Delavirdine mesylate" (2 trials), "Edwards PASCAL System" (2 trials), "AMPLATZER™ PFO Occluder" (1 trials) and "Abbott Mitraclip System" (1 trials). Other intervention names were less common.

The vast majority of trials in "HCA Houston Healthcare Medical Center" are 18 trials for "All" genders.

Currently, there are NaN active trials in "HCA Houston Healthcare Medical Center". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in HCA Houston Healthcare Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in HCA Houston Healthcare Medical Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".